Assessment of vascular and endothelial dysfunction in nutritional studies

Nutrition, Metabolism and Cardiovascular Diseases

Volumn 24, Issue 9, 2014, Pages 940-946

  Ray, S ^a   Miglio, C ^b   Eden, T ^b   Del Rio, D ^c  

^a MEDICAL RESEARCH COUNCIL   (United Kingdom)

^b The Need for Nutrition Education Innovation Programme (NNEdPro) C o MRC HNR   (United Kingdom)

^c UNIVERSITY OF PARMA   (Italy)

Author keywords

Cardiovascular disease and fruit juice; Endothelial (dys) function; Polyphenols; Vascular (dys) function

Indexed keywords

NITRIC OXIDE; REACTIVE OXYGEN METABOLITE; POLYPHENOL;

ARTERIAL STIFFNESS; ARTERIAL WALL THICKNESS; DIET SUPPLEMENTATION; DYSLIPIDEMIA; ENDOTHELIAL DYSFUNCTION; FRUIT JUICE; IONTOPHORESIS; NUTRITION; PRIORITY JOURNAL; PULSE WAVE; SHORT SURVEY; SMOKING; VASCULAR AND ENDOTHELIAL DYSFUNCTION; BEVERAGE; CLINICAL TRIAL (TOPIC); FACTUAL DATABASE; FRUIT; HUMAN; PATHOPHYSIOLOGY; RISK FACTOR; VASCULAR DISEASES; VASCULAR ENDOTHELIUM;

BEVERAGES; CLINICAL TRIALS AS TOPIC; DATABASES, FACTUAL; ENDOTHELIUM, VASCULAR; FRUIT; HUMANS; POLYPHENOLS; RISK FACTORS; VASCULAR DISEASES;

EID: 84953391661     PISSN: 09394753     EISSN: 15903729     Source Type: Journal    
DOI: 10.1016/j.numecd.2014.03.011     Document Type: Short Survey

References (37)

1. Chen K., Keaney J.F. Evolving concepts of oxidative stress and reactive oxygen species in cardiovascular disease. Curr Atheroscler Rep 2012, 14:476-483.
2. Vita J.A., Keaney J.F. Endothelial function: a barometer for cardiovascular risk?. Circulation 2002, 106:640-642.
3. Hooper L., Kroon P.A., Rimm E.B., Cohn J.S., Harvey I., Le Cornu K.A., et al. Flavonoids, flavonoid-rich foods, and cardiovascular risk: a meta-analysis of randomized controlled trials. Am J Clin Nutr 2008, 88:38-50.
4. Chong M.F., Macdonald R., Lovegrove J.A. Fruit polyphenols and CVD risk: a review of human intervention studies. Br J Nutr 2010, 104:S28-S39.
5. Vane J.R., Anggård E.E., Botting R.M. Regulatory functions of the vascular endothelium. N Engl J Med 1990, 323:27-36.
6. Deanfield J.E., Halcox J.P., Rabelink T.J. Endothelial function and dysfunction: testing and clinical relevance. Circulation 2007, 115:1285-1295.
7. Hagen T. Mechanisms of cardiovascular aging, in advances of cell aging and gerontology 2002, vol. 11. University of Michigan (USA), Elsevier, p. 403.
8. Münzel T., Sinning C., Post F., Warnholtz A., Schulz E. Pathophysiology, diagnosis and prognostic implications of endothelial dysfunction. Ann Med 2008, 40:180-196.
9. Moncada S., Higgs A. The L-arginine-nitric oxide pathway. N Engl J Med 1993, 329:2002-2012.
10. Braam B., Verhaar M.C. Understanding eNOS for pharmacological modulation of endothelial function: a translational view. Curr Pharm Des 2007, 13:1727-1740.
11. Anderson T.J., Uehata A., Gerhard M.D., Meredith I.T., Knab S., Delagrange D., et al. Close relation of endothelial function in the human coronary and peripheral circulations. J Am Coll Cardiol 1995, 26:1235-1241.
12. Matsuo S., Matsumoto T., Takashima H., Ohira N., Yamane T., Yasuda Y., et al. The relationship between flow-mediated brachial artery vasodilation and coronary vasomotor responses to bradykinin: comparison with those to acetylcholine. J Cardiovasc Pharmacol 2004, 44(2):164-170.
13. Deanfield J., Donald A., Ferri C., Giannattasio C., Halcox J., Halligan S., et al. Endothelial function and dysfunction. part I: methodological issues for assessment in the different vascular beds: a statement by the working group on endothelin and endothelial factors of the European Society of Hypertension. J Hypertens 2005, 23(1):7-17.
14. Brevetti G., Silvestro A., Schiano V., Chiariello M. Endothelial dysfunction and cardiovascular risk prediction in peripheral arterial disease: additive value of flow-mediated dilation to ankle-brachial pressure index. Circulation 2003, 108(17):2093-2098.
15. Thijssen D.H., Black M.A., Pyke K.E., Padilla J., Atkinson G., Harris R.A., et al. Assessment of flow-mediated dilation in humans: a methodological and physiological guideline. Am J Physiol Heart Circ Physiol 2011, 300:H2-H12.
16. Roman M.J., Devereux R.B., Kizer J.R., Lee E.T., Galloway J.M., Ali T., et al. Central pressure more strongly relates to vascular disease and outcome than does brachial pressure. Hypertension 2007, 50:197-203.
17. Weber T., Auer J., Lamm G., O'Rourke M.F., Eber B. Arterial stiffness, central blood pressures, and wave reflections in cardiomyopathy-implications for risk stratification. J Card Fail 2007, 13:353-359.
18. Dengel D.R., Bronas U.G. The role of endothelial dysfunction on development and progression of atherosclerosis and methods to assess vascular function and structure. Am J Lifestyle Med 2010, 4:445-456.
19. Rosenbaum D., Giral P., Chapman J., Rached F.H., Kahn J.F., Bruckert E., et al. Radial augmentation index is a surrogate marker of atherosclerotic burden in a primary prevention cohort. Atherosclerosis 2013, 231:436-441.
20. Nagai K., Shibata S., Akishita M., Sudoh N., Obara T., Toba K., et al. Efficacy of combined use of three non-invasive atherosclerosis tests to predict vascular events in the elderly; carotid intima-media thickness, flow-mediated dilation of brachial artery and pulse wave velocity. Atherosclerosis 2013, 231:365-370.
21. Verbeke F., Maréchal C., Van Laecke S., Van Biesen W., Devuyst O., Van Bortel L.M., et al. Prognostic value of aortic stiffness and calcification for cardiovascular events and mortality in dialysis patients: outcome of the calcification outcome in renal disease (CORD) study. Clin J Am Soc Nephrol 2011, 6:153-159.
22. Cruickshank K., Riste L., Anderson S.G., Wright J.S., Dunn G., Gosling R.G. Aortic pulse-wave velocity and its relationship to mortality in diabetes and glucose intolerance: an integrated index of vascular function?. Circulation 2002, 106:2085-2090.
23. Hansell J., Henareh L., Agewall S., Norman M. Non-invasive assessment of endothelial function - relation between vasodilatory responses in skin microcirculation and brachial artery. Clin Physiol Funct Imaging 2004, 24:317-322.
24. Ferrell W.R., Ramsay J.E., Brooks N., Lockhart J.C., Dickson S., McNeece G.M., et al. Elimination of electrically induced iontophoretic artefacts: implications for non-invasive assessment of peripheral microvascular function. J Vasc Res 2002, 39:447-455.
25. Lorenz M.W., Schaefer C., Steinmetz H., Sitzer M. Is carotid intima media thickness useful for individual prediction of cardiovascular risk? Ten-year results from the Carotid Atherosclerosis Progression Study (CAPS). Eur Heart J 2010, 31:2041-2048.
26. Alderson P., Green S., Higgins J. Highly sensitive search strategies for identifying report of randomized controlled trials in MEDLINE 2004, Cochrane reviewer's handbook 4.2. 2; appendix 5b. The Cochrane Library. The Cochrane Collaboration, John Wiley & Sons, Ltd, Chichester, UK, (3).
27. Critical appraisal skills programme. Appraisal tools. UK: Oxford; [accessed June 2012]. http://www.phru.nhs.uk/casp/reviews.pdf.
28. Dohadwala M.M., Holbrook M., Hamburg N.M., Shenouda S.M., Chung W.B., Titas M., et al. Effects of cranberry juice consumption on vascular function in patients with coronary artery disease. Am J Clin Nutr 2011, 93:934-940.
29. Stein J.H., Keevil J.G., Wiebe D.A., Aeschlimann S., Folts J.D. Purple grape juice improves endothelial function and reduces the susceptibility of LDL cholesterol to oxidation in patients with coronary artery disease. Circulation 1999, 100:1050-1055.
30. Chou E.J., Keevil J.G., Aeschlimann S., Wiebe D.A., Folts J.D., Stein J.H. Effect of ingestion of purple grape juice on endothelial function in patients with coronary heart disease. Am J Cardiol 2001, 88:553-555.
31. Buscemi S., Rosafio G., Arcoleo G., Mattina A., Canino B., Montana M., et al. Effects of red orange juice intake on endothelial function and inflammatory markers in adult subjects with increased cardiovascular risk. Am J Clin Nutr 2012, 95:1089-1095.
32. Lynn A., Hamadeh H., Leung W.C., Russell J.M., Barker M.E. Effects of pomegranate juice supplementation on pulse wave velocity and blood pressure in healthy young and middle-aged men and women. Plant Foods Hum Nutr 2012, 67:309-314.
33. Ruel G., Pomerleau S., Couture P., Lamarche B., Couillard C. Changes in plasma antioxidant capacity and oxidized low-density lipoprotein levels in men after short-term cranberry juice consumption. Metabolism 2005, 54:856-861.
34. Siasos G., Tousoulis D., Kokkou E., Oikonomou E., Kollia M.E., Verveniotis A., et al. Favorable effects of concord grape juice on endothelial function and arterial stiffness in healthy smokers. Am J Hypertens 2014 Jan, 27(1):38-45.
35. Aviram M., Rosenblat M., Gaitini D., Nitecki S., Hoffman A., Dornfeld L., et al. Pomegranate juice consumption for 3 years by patients with carotid artery stenosis reduces common carotid intima-media thickness, blood pressure and LDL oxidation. Clin Nutr 2004, 23:423-433.
36. Davidson M.H., Maki K.C., Dicklin M.R., Feinstein S.B., Witchger M., Bell M., et al. Effects of consumption of pomegranate juice on carotid intima-media thickness in men and women at moderate risk for coronary heart disease. Am J Cardiol 2009, 104:936-942.
37. Morand C., Dubray C., Milenkovic D., Lioger D., Martin J.F., Scalbert A., et al. Hesperidin contributes to the vascular protective effects of orange juice: a randomized crossover study in healthy volunteers. Am J Clin Nutr 2011, 93:73-80.